Clinical Trial Update: Venetoclax- Augmented Treosulfan-Based Reduced Intensity Conditioning Before Allogeneic Stem Cell Transplantation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating venetoclax-augmented treosulfan-based reduced-intensity conditioning before allogeneic stem cell transplantation in AML and my…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• Treosulfan (treosulfan)
• Venetoclax (venetoclax)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: AML (Acute Myeloid Leukemia), MDS/AML | Phase 2 | Status: NOT_YET_RECRUITING